Psylaris
-49%
est. 2Y upside i
Psychotherapy through autonomous and personalized VR-sessions.
Rank
#482
Sector
Mental Health Tech
Est. Liquidity
~5Y
Data Quality
Data: MediumPsylaris operates in a rapidly growing and innovative sector with a strong product offering and recent investment, suggesting moderate upside potential.
Last updated: February 23, 2026
Psylaris achieves significant market penetration across Europe, expands its VR therapy modules, and secures a strong Series B/C round at a substantially higher valuation, leading to a successful acquisition or IPO.
Psylaris continues steady growth, expands its user base and product offerings, and is acquired by a larger healthcare tech company at a fair valuation within 5-7 years.
Psylaris faces intense competition, slower-than-expected adoption, or regulatory hurdles, leading to a down round or an acquisition at a valuation significantly below the current level.
Preference Stack Risk
moderateAssuming a total funding of €10M and a current valuation of €40M, investors hold €10M in liquidation preferences. This means in an exit at or below €10M, common shareholders may receive little to nothing. At the assumed current valuation of €40M, this represents a 25% investor take.
Dilution Risk
moderateAs an early-stage company (assumed Series A), Psylaris will likely undergo several more funding rounds to fuel its European expansion and product development, which will dilute existing equity holders.
Secondary Liquidity
noneThere is currently no active secondary market for Psylaris shares, limiting liquidity for employees.
Community
Valuation Sentiment
Our model estimates -49% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.